Hrt Financial LP Gossamer Bio, Inc. Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.8 - $1.51 $439,794 - $830,111	549,743 Added 4462.92%	562,061 $663,000
Q4 2023 Feb 09, 2024	BUY	$0.48 - $1.08 $5,912 - $13,303	12,318 New	12,318 $11,000
Q1 2023 May 12, 2023	BUY	$0.96 - $2.92 $1.49 Million - $4.52 Million	1,548,153 New	1,548,153 $1.95 Million
Q2 2022 Aug 12, 2022	SELL	$5.97 - $9.97 $60,744 - $101,444	-10,175 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $12,288 - $18,185	-1,456 Reduced 12.52%	10,175 $88,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $56,368 - $78,369	-5,570 Reduced 32.38%	11,631 $131,000
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $124,707 - $227,569	17,201 New	17,201 $216,000
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $96,328 - $117,399	-12,041 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $103,913 - $131,728	12,041 New	12,041 $111,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $78.9M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.